Intelligence · Clinical Pipeline
Xenon Pharmaceuticals Pipeline
All ClinicalTrials.gov programs at Xenon Pharmaceuticals — phase, modality, and trial IDs.
- Programs
- 10
Quick answer
Xenon Pharmaceuticals has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Azetukalner
Xenon Pharmaceuticals
Bipolar Depression
1 trial -
Azetukalner
Xenon Pharmaceuticals
Major Depressive Disorder
3 trials -
Azetukalner
Xenon Pharmaceuticals
Bipolar Disorder
1 trial -
Placebo, XPF-010
Xenon Pharmaceuticals
Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)
1 trial -
XEN1101
Xenon Pharmaceuticals
Focal Epilepsy
2 trials -
XEN1101
Xenon Pharmaceuticals
Focal Onset Seizures
2 trials -
XEN1101
Xenon Pharmaceuticals
Primary Generalized Tonic-Clonic Seizures
1 trial -
XEN496
Xenon Pharmaceuticals
Epilepsy
2 trials -
XPF-010
Xenon Pharmaceuticals
Depressive episodes associated with Bipolar disorder I or II (Bipolar Depression)
1 trial -
XPF-010, Placebo to match XPF-010
Xenon Pharmaceuticals
Major Depressive Disorder
1 trial
Frequently asked questions
How many pipeline programs does Xenon Pharmaceuticals have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs